I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Rationale and design of the Children's Oncology Group (COG)..:
Armenian, Saro
;
Hudson, Melissa
;
Chen, Ming
...
http://www.biomedcentral.com/1471-2261/16/187. , 2016
Link:
http://www.biomedcentral.com/1471-2261/16/187
RT Journal T1
Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure
UL https://suche.suub.uni-bremen.de/peid=base-ftbiomed:oai:biomedcentral.com:s12872-016-0364-6&Exemplar=1&LAN=DE A1 Armenian, Saro A1 Hudson, Melissa A1 Chen, Ming A1 Colan, Steven A1 Lindenfeld, Lanie A1 Mills, George A1 Siyahian, Aida A1 Gelehrter, Sarah A1 Dang, Ha A1 Hein, Wendy A1 Green, Daniel A1 Robison, Leslie A1 Wong, F A1 Douglas, Pamela A1 Bhatia, Smita PB BioMed Central Ltd. YR 2016 K1 Childhood cancer K1 Survivors K1 Cardiomyopathy K1 Heart failure K1 Anthracyclines K1 Risk reduction K1 Carvedilol JF http://www.biomedcentral.com/1471-2261/16/187 LK http://www.biomedcentral.com/1471-2261/16/187 DO http://www.biomedcentral.com/1471-2261/16/187 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)